1. Blog

HOMA-IR: the assumptions inside the calculation

HOMA-IR is a calculated estimate based on fasting glucose and fasting insulin, designed to describe the balance between insulin output and glucose regulation under steady fasting conditions. It is useful in research and selected clinical contexts, but…

8 min de lectura

En este artículo
  1. What HOMA-IR calculates
  2. What a high or low result can mean
  3. How it is measured and what affects the result
  4. Who might ask for it and when
  5. HOMA-IR at Santé Labs
  6. FAQ

HOMA-IR is a calculated estimate based on fasting glucose and fasting insulin, designed to describe the balance between insulin output and glucose regulation under steady fasting conditions. It is useful in research and selected clinical contexts, but it has no single universal cut-off and is not one of the standard tests used to diagnose diabetes [1,2,3].

Key takeaways

  • HOMA-IR is calculated, not measured directly: both fasting glucose and fasting insulin must be valid for the result to be meaningful [1].
  • The original HOMA model represents feedback between the liver and pancreatic beta cells during fasting; the simple formula is an approximation of that model [1,2].
  • Insulin assays are not fully interchangeable, and reported HOMA-IR thresholds vary by population, age, sex and study design [2,4].
  • A fasting glucose, HbA1c or oral glucose tolerance test is used for diabetes diagnosis; HOMA-IR does not replace them [3].
  • A result should be interpreted against the laboratory method, local reference information and the reason it was requested, not an internet cut-off.

What HOMA-IR calculates

HOMA stands for homeostasis model assessment, and IR stands for insulin resistance. The model was introduced in 1985 to estimate insulin resistance and beta-cell function from basal, or fasting, glucose and insulin concentrations [1]. It describes a feedback loop: glucose stimulates insulin secretion, while insulin restrains liver glucose output.

The commonly used HOMA1-IR approximation is:

fasting insulin (µU/mL) × fasting glucose (mmol/L) ÷ 22.5

When glucose is expressed in mg/dL, the corresponding form is:

fasting insulin (µU/mL) × fasting glucose (mg/dL) ÷ 405

These equations arise from the original model [1,2]. Units must match the chosen equation. Copying a glucose value in mg/dL into the mmol/L formula produces a result that is wrong by a large factor, even though the arithmetic itself may look tidy.

Consider an illustrative fasting glucose of 90 mg/dL and fasting insulin of 10 µU/mL. The mg/dL equation gives 10 × 90 ÷ 405 = 2.22. Using an equivalent glucose of 5.0 mmol/L in the other equation gives 10 × 5.0 ÷ 22.5 = 2.22. This demonstrates unit consistency, not a diagnosis or a target.

HOMA2 is a later computer model that accounts for more of the nonlinear relationship between glucose and insulin. Oxford's Diabetes Trials Unit provides a HOMA2 calculator for use in people with or without diabetes who are not receiving insulin therapy [5]. A HOMA1 value from the simple equation and a HOMA2 output should not be treated as the same measurement.

What a high or low result can mean

A result is not a diagnosis. In a comparable population, a higher HOMA-IR generally represents a pattern of more fasting insulin for the prevailing fasting glucose and can be consistent with lower insulin sensitivity. A lower value generally represents less fasting insulin relative to glucose, but unusually low insulin can also need context if glucose regulation is abnormal.

Result pattern What can reasonably be said What cannot be concluded
Higher than a locally validated reference or study threshold The fasting glucose-insulin relationship suggests greater estimated insulin resistance within that specific framework [2,4]. It does not diagnose diabetes, identify the cause or establish that treatment is required.
Near a quoted research cut-off Classification may change with assay, population or chosen threshold [2,4]. A decimal difference does not prove a biological change.
Lower than a comparison value May indicate greater estimated fasting insulin sensitivity when glucose and insulin are both valid. It is not automatically “better,” especially if insulin secretion is impaired or the sample was not truly fasting.
Not calculable or unreliable Non-fasting sampling, out-of-range inputs, insulin therapy or assay concerns can invalidate the estimate [2,5]. The formula should not be forced onto unsuitable values.

There is no agreed universal boundary separating “normal” from “insulin resistant.” Reviews describe substantial threshold variation with demographic characteristics and study methods [4]. A value used in one research cohort may classify a different population poorly.

HOMA-IR also compresses two changing measurements into one number. The same calculated value can arise from different glucose and insulin pairs. For example, a relatively higher insulin with lower glucose may yield a similar number to lower insulin with higher glucose, while those patterns can have different clinical implications.

Diabetes and prediabetes have separate diagnostic pathways. NIDDK lists fasting plasma glucose, HbA1c and the oral glucose tolerance test, with repeat confirmation usually required when there are no unequivocal symptoms [3]. Those thresholds classify glycaemia; HOMA-IR estimates a physiological relationship and should not be substituted for them.

How it is measured and what affects the result

The two inputs usually come from the same fasting venous sample. Reliable interpretation assumes a reasonably steady fasting state, correct specimen processing and assays suited to the calculation. The formula cannot correct a weak input.

Factors to document include:

  1. The exact fasting period and whether anything besides water was consumed.
  2. The sampling time, because glucose and insulin biology can vary through the day.
  3. Acute illness, poor sleep, unusual exercise or stress that differs from the usual state.
  4. Medicines and supplements that can affect glucose or insulin.
  5. Pregnancy, puberty and other physiological contexts where comparison ranges differ.
  6. Whether insulin therapy is being used; the Oxford HOMA2 tool is not intended for people receiving insulin [5].

Sample handling particularly affects glucose because cells continue to consume it after collection unless processing limits that change. Insulin results also depend on the assay. Unlike glucose, insulin measurements have historically shown material differences among methods, one reason that a HOMA-IR cut-off cannot be transferred casually between laboratories or studies [2].

For a repeat measurement, use comparable conditions where practical: the same laboratory, similar fasting duration and similar collection time. Even then, biological and analytical variation means that a small difference may not represent a meaningful change.

Before calculating a value yourself, check three items on the report:

  • Was glucose measured in plasma and in which unit?
  • Which insulin unit and assay does the laboratory report?
  • Does the laboratory provide its own calculation or interpretive information?

Do not stop prescribed medicines to create a “cleaner” result. Ask the requesting doctor which preparation is safe and relevant to the clinical question.

Who might ask for it and when

HOMA-IR is common in epidemiology, metabolic research and studies comparing groups because it is much simpler than dynamic techniques such as the hyperinsulinaemic-euglycaemic clamp. Its convenience does not make it a direct measurement, and correlations with clamp methods vary by population and metabolic state [2].

In clinical practice, a specialist may use it as supporting information in a defined metabolic, endocrine or research pathway. Whether it adds value depends on the question. A calculated index is less useful when the immediate question is simply whether someone meets established criteria for diabetes or prediabetes, because validated glucose and HbA1c pathways already address that question [3].

If HOMA-IR appears on a report, ask your doctor:

  • Was HOMA1 calculated, or did the laboratory use HOMA2?
  • Were both inputs collected during a valid fast?
  • Which insulin assay and comparison range were used?
  • Is the quoted cut-off validated for people like me?
  • How do the individual glucose and insulin results look, not just their product?
  • Would fasting glucose, HbA1c or an oral glucose tolerance test answer the clinical question more directly?
  • Would repeating the test under comparable conditions change a decision?

Symptoms such as marked thirst, frequent urination, unexplained weight loss, vomiting or drowsiness need prompt medical attention. Do not delay assessment while trying to calculate HOMA-IR.

HOMA-IR at Santé Labs

Santé Labs' verified catalogue does not establish HOMA-IR or fasting insulin as part of a currently bookable profile. The bookable Glycaemic Control Profile explicitly does not include insulin or HOMA-IR, so its glucose result alone cannot be used to create this index.

The verified facts also do not name a coming-soon profile that is confirmed to contain both inputs. Ask Santé Labs to confirm current contents and availability, and discuss with your doctor whether the calculation would add useful information before arranging separate tests.

FAQ

What is a normal HOMA-IR value?

There is no universal normal cut-off. Thresholds vary with the insulin assay, population, age, sex and purpose of the study [2,4]. Use only a range validated by the reporting service and interpreted for your clinical context.

Can HOMA-IR diagnose prediabetes or diabetes?

No. Standard diagnosis uses laboratory glucose and HbA1c pathways, often with repeat confirmation; HOMA-IR is not a listed diagnostic criterion [3]. A normal-looking HOMA-IR should not overrule an abnormal diagnostic test, or vice versa.

Why did my HOMA-IR change when glucose barely moved?

The index multiplies glucose by insulin, so a change in insulin can move the result even when glucose looks stable. Fasting conditions, illness, biological variation and the insulin assay also matter.

Are HOMA1 and HOMA2 the same?

No. HOMA1 usually refers to the simple formula, while HOMA2 is a computer model that incorporates nonlinear relationships [2,5]. Their numerical outputs should not be compared as if they came from the same equation.

Can I calculate it from a home glucose meter?

That is not a reliable substitute for paired laboratory fasting measurements. Home meters do not measure insulin, and diagnostic guidance also distinguishes laboratory plasma glucose from meter readings [3].

References

  1. Matthews DR et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 1985 – https://pubmed.ncbi.nlm.nih.gov/3899825/
  2. Wallace TM et al., Use and abuse of HOMA modeling, Diabetes Care, 2004 – https://pubmed.ncbi.nlm.nih.gov/15161807/
  3. National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Tests & Diagnosis, 2022 – https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis
  4. Tahapary DL et al., Challenges in the diagnosis of insulin resistance: focusing on HOMA-IR and the triglyceride/glucose index, Diabetes & Metabolic Syndrome, 2022 – https://pubmed.ncbi.nlm.nih.gov/35939943/
  5. University of Oxford Diabetes Trials Unit, HOMA2 Calculator, 2017 – https://www2.dtu.ox.ac.uk/generic/article.php?ArticleID=303
Compartir

Plan Superhuman

Mide tu ApoB.Y más de 100 biomarcadores en total.

Una analítica completa al año en el laboratorio y un plan de acción claro.

495 € al año, con renovación anual. Cancela la renovación desde la app. Si tu médico no aprueba la solicitud, te devolvemos todo lo pagado. La lista exacta depende de tu sexo y tu edad.

Sigue leyendo

Artículos relacionados.Para leer junto a este.

Ver el blog
Ver el blog